New Research from Orthohealing Center’s Dr Steven Sampson & Dr Danielle Aufiero on the world’s largest placebo controlled PRP trial on tennis elbow, presented at the AAOS in Chicago IL.

Platelet-Rich Plasma Significantly Improves Clinical Outcomes in Patients with Chronic Tennis Elbow:
A Double-Blind, Prospective, Multicenter, Controlled Trial of 230 Patients

Allan K. Mishra,  MD; Nebojsa V. Skrepnik, MD, PhD; Scott G. Edwards, MD; Grant L. Jones, MD; Steven Sampson, DO; Doug A. Vermillion, MD; Matthew L. Ramsey, MD; David C. Karli, MD, MBA; Arthur C. Rettig, MD

Dr Steven Sampson travelled to Chicago for the world’s largest gathering of orthopaedic surgeons (AAOS) as a Principal Investigator in the world’s largest placebo controlled PRP trial.  The study was a randomized, double-blind, multi-center controlled trial of 230 patients.  Patients received needling of their elbow tendons with and without PRP.  At 24 weeks the PRP patients reports a 71.5% improvement in their pain compared to 56.1 in the control group. (P = 0.027)  Patients treated with PRP also had less elbow tenderness at each follow up point. Overall, 84% of the PRP patients were successfully treated compared to 68.3% of the control group. (P = 0.012)

84% of patients with chronic tennis elbow who had failed other non-operative treatments were successfully treated using platelet-rich plasma (PRP) in a large randomized trial.

There are now over 340 patients who have been treated confirming the value of PRP as a treatment for chronic tennis elbow.  Importantly, there is also a decade long experience using PRP with an excellent safety profile.  PRP with this newly released data can now be confidently used for chronic tennis elbow patients prior to considering surgical intervention.

The results will be presented by Dr. Allan K. Mishra at TOBI 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Event details and registration online at

This study took 6 years to produce and validate the findings we have seen in our clinics for years. More and more robust trials are coming to further clarify the role for PRP and regenerative procedures in the near future.

View Abstract:

For more of the latest PRP research and clinical experience, plus networking with field leaders, attend The Orthobiologic Institute (TOBI) 4th Annual PRP & Regenerative Medicine Symposium, June 7-8, 2013 in Los Angeles. Details and registration at Early Rates through March 31st – Register Now!

This field is for validation purposes and should be left unchanged.

Get on the path to comprehensive healing and long-term pain relief today.

Accessibility Toolbar

Request an Appointment
Scroll to Top